Resmed Inc
NYSE:RMD
Resmed Inc
EPS (Diluted)
Resmed Inc
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Resmed Inc
NYSE:RMD
|
EPS (Diluted)
$8
|
CAGR 3-Years
19%
|
CAGR 5-Years
20%
|
CAGR 10-Years
14%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
EPS (Diluted)
$6
|
CAGR 3-Years
1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
0%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
EPS (Diluted)
$1
|
CAGR 3-Years
37%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
EPS (Diluted)
$7
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
19%
|
|
|
Abbott Laboratories
NYSE:ABT
|
EPS (Diluted)
$7
|
CAGR 3-Years
21%
|
CAGR 5-Years
31%
|
CAGR 10-Years
11%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
EPS (Diluted)
$6
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
17%
|
|
Resmed Inc
Glance View
ResMed Inc. has built its legacy on a profound, technological commitment to improving the lives of millions worldwide who suffer from sleep-related breathing disorders. Emerging as a beacon in the field of medical device innovation, the company is renowned for its focus on designing and manufacturing equipment to treat sleep apnea, a condition where breathing repeatedly stops and starts during sleep. Their product line, which includes continuous positive airway pressure (CPAP) devices, ventilators, and masks, caters to hospitals, home healthcare settings, and individuals. By addressing this critical health issue, ResMed doesn't just deliver therapeutic equipment; it offers a lifeline to those battling sleep health challenges, ensuring that restful nights translate into healthier days. The company's revenue model pivots around an integrated approach combining hardware sales, software solutions, and cloud-connected offerings. Through its software, ResMed analyzes vast pools of patient data, enabling healthcare providers to tailor and improve therapeutic protocols, thus driving the efficacy of treatment plans. The increasing turn towards digital health technologies has also opened new avenues, with the company's cloud platforms and analytics delivering value-added insights to care providers. This convergence of medical equipment and digital technology provides ResMed not just a steady growth trajectory, but also positions it at the forefront of a healthcare evolution, turning data-driven intelligence into actionable health solutions.
See Also
What is Resmed Inc's EPS (Diluted)?
EPS (Diluted)
8.9
USD
Based on the financial report for Mar 31, 2025, Resmed Inc's EPS (Diluted) amounts to 8.9 USD.
What is Resmed Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
14%
Over the last year, the EPS (Diluted) growth was 37%. The average annual EPS (Diluted) growth rates for Resmed Inc have been 19% over the past three years , 20% over the past five years , and 14% over the past ten years .
You don't have any saved screeners yet